148549-71-7

Upstream product

• 124750-71-6 2-butyl-4-chloro-1H-imidazole-5-carboxylic acid,methyl ester 
• 100-11-8 1-bromomethyl-4-nitro-benzene 

Downstream Products

• 142219-28-1 (S) Methyl 2-butyl-4-chloro-1-[[4-[[2-[2-(methoxycarbonyl)-1H-pyrrol-1-yl]-1 oxo-3-phenylpropyl]amino]phenyl]methyl]-1H-imidazole-5-carboxylate 
• 148549-79-5 2-Butyl-5-chloro-3-{4-[(S)-2-(2-methoxycarbonyl-pyrrol-1-yl)-3-thiophen-2-yl-propionylamino]-benzyl}-3H-imidazole-4-carboxylic acid methyl ester 
• 148549-77-3 (S)-methyl 2-butyl-1-{[4-({2-[2-(carbomethoxy)-1H-pyrrol-1-yl]-1-oxo-3-phenylpropyl}amino)phenyl]methyl}-1H-imidazole-5-carboxylate 
• 148549-90-0 2-Butyl-5-chloro-3-[4-((S)-2-pyrrol-1-yl-3-thiophen-2-yl-propionylamino)-benzyl]-3H-imidazole-4-carboxylic acid methyl ester 
• 148550-16-7 methyl 2-butyl-5-chloro-3-<(4-aminophenyl)methyl>-3H-imidazole-5-carboxylate 

Relevant academic research and scientific papers

Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4[[[(1H-pyrrol-1- ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists

A novel series of non-biphenylyltetrazole angiotensin II receptor antagonists which contain a 1H-pyrrol-1-ylacetyl residue in place of the benzoyl residue in EXP 6803 have been developed. The receptor binding activity of several members of this new series